Thailand
Industry
BMI View: Thailand's medical device sector will be boosted by the government's continued effort to promote medical tourism, as well as the increasingly ageing population that will...
2011-10-25Industry
BMI View: In countries with under-developed healthcare systems, the presence of non-governmental organisations (NGOs) providing medical aid is essential. Government efforts to improve...
2011-10-06Industry
BMI View: Thailand will remain attractive to bold investors according to its score in our proprietary pharmaceuticals and healthcare Business Environment Ratings (BERs). In addition...
2011-07-14Industry
BMI View: Attention deficit hyperactivity disorder (ADHD) represents a small but growing opportunity for pharmaceutical companies operating in South East Asia. The prevalence of the...
2011-05-04Industry
BMI View: Thailand's THB127bn (US$3.96bn) pharmaceutical market represents a moderate proposition to multinational pharmaceutical companies. Although projected growth is robust (five-year...
2011-02-22Industry
BMI View: Asia Pacific's attractiveness to multinational drugmakers is faltering. BMI's Pharmaceuticals & Healthcare Business Environment Ratings (BERs), which assess countries...
2011-01-14Industry
BMI View: Thailand's liberal pharmaceutical pricing regime is in need of reform. The current framework favours the interests of drugmakers over patient welfare, which is leading to...
2011-01-12Economy
Developed state underperformance remains a recurring theme within our Industry analysis. We remain concerned about US labour market weakness and its impact, particularly on consumer...
2010-09-28
